| 000 | 01132 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250516150522.0 | ||
| 264 | 0 | _c20131223 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1662-2979 | ||
| 024 | 7 |
_a10.1159/000346056 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIsgaard, Jörgen | |
| 245 | 0 | 0 |
_aGhrelin and the cardiovascular system. _h[electronic resource] |
| 260 |
_bEndocrine development _c2013 |
||
| 300 |
_a83-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
| 650 | 0 | 4 |
_aCardiovascular Physiological Phenomena _xdrug effects |
| 650 | 0 | 4 |
_aCardiovascular System _xdrug effects |
| 650 | 0 | 4 |
_aGhrelin _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIschemia _xprevention & control |
| 650 | 0 | 4 | _aModels, Biological |
| 650 | 0 | 4 |
_aVasoconstrictor Agents _xpharmacology |
| 773 | 0 |
_tEndocrine development _gvol. 25 _gp. 83-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000346056 _zAvailable from publisher's website |
| 999 |
_c22732217 _d22732217 |
||